Skip to content

Corix Bioscience, Inc.

company.status.inactive

CIK 1433821fmd_1AXENKARCJTC2JD1M9QX5S24RJFinance, Insurance and Real Estate · Operators of Nonresidential BuildingsTemplate: Real estate

Coverage: Feb 01, 2007 to Sep 30, 2017, 34 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012FY2013FY2014FY2014FY2015FY2015FY2016
Total revenues––––0–0–01
Rental revenue––––––––01
Depreciation and amortization––––––––00
Gain on sale of real estate––––––1–0–
Total operating expenses––1020––35
Impairment of real estate––––––––0(0)
Operating income–––(0)(2)(0)––(3)–
Funds from operations (NAREIT definition, derived)––––––––(3)(4)
Interest expense–––0(0)(0)––00
Income before taxes–––(0)(2)–––(3)(4)
Income tax expense–––––0–0––
Net income from continuing operations––––––––(3)–
Net income(0)(0)(1)(0)(2)–(1)–(3)(4)
Net income to common shareholders––––––––(3)(4)
Corix Bioscience, Inc. financial statements · FinancialMD